The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People
Status:
Unknown status
Trial end date:
2018-09-20
Target enrollment:
Participant gender:
Summary
This study was a single center, parallel, randomized, double blind, placebo-controlled phase
Ib clinical trial to to evaluate the safety and tolerability and pharmacokinetics of SPH3127
tablet in healthy subjects by increasing multiple dosing